Page 499 - O_Desenvolvimento_do_Autismo
P. 499

DANYSZ, W. “CX-516 Cortex pharmaceuticals”. Current Opinion in
                Investigational Drugs 3(7), 2002, pp. 1.081-1.088.






                DAWSON, G. e LEVY, A. “Arousal, attention and the socioemotional
                adjustment of individuals with autism”. In: G. Dawson (ed.). Autism: nature,

                diagnosis and treatment. Nova York: Guilford, 1989.






                DAY, J. D.; CORDON, L. A. e KERWIN, M. L. “Informal instruction and
                development of cognitive skills: a review and critique of research”. In: C. B.
                McCormick; G. Miller e M. Pressley (eds.). Cognitive strategy research:
                from basic research to educational applications. Nova York: Springer-
                Verlag, 1989.






                DELGIUDICE-ASCH, G.; SIMON, L.; SCHMEIDLER, J.; CUNNINGHAM-
                RUNDLES, C. e HOLLANDER, E. “Brief report: a pilot open clinical trial

                of intravenous immunoglobulin in childhood autism”. Journal of Autism and
                Developmental Disorders 29, 1999, pp. 157-160.






                DENHAM, S.; BLAIR, K.; DEMULDER, E.; LEVITAS, J.; SAWYER, K.;
                AUERBACH-MAJOR, S. e QUEENAN, P. “Preschool emotional
                competence: pathway to social competence”. Child Development 74, 2003,
                pp. 238-256.






                D’EUFEMIA, P.; CELLI, M.; FINOCCHIARO, R.; PACIFICO, L.; VIOZZI,

                L.; ZACCAGNINI, M.; CARDI, E. e GIARDINI, O. “Abnormal intestinal
                permeability in children with autism”. Acta Paediatrica 85(9), 1996, pp.
                1.076-1.079.
   494   495   496   497   498   499   500   501   502   503   504